Why the study?
What are the epidemiological, clinical, and biological parameters associated with neuroleptic malignant syndrome?
Population
120 case reports of neuroleptic malignant syndrome (NMS)
Design
Review
Authors
Loading...
May support slower neuroleptic titration to lower NMS risk; leaves open prospective validation of loading rate.
What are the epidemiological, clinical, and biological parameters associated with neuroleptic malignant syndrome?
This review highlights that the rate of neuroleptic loading is a critical factor in the development of neuroleptic malignant syndrome.
Shalev et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: